Autoimmune Disease Diagnosis Market to Grow at a CAGR of 8.9%, Top Key Players EUROIMMUN AG, Protagen AG, HYCOR, nova Diagnostics, Trinity Biotech, Quest Diagnostics Bandera County Courier
Kiniksa Announces Early Evidence of Treatment Response with Mavrilimumab in 6 Patients with Severe COVID-19 Pneumonia and Hyperinflammation Yahoo Finance
Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study DocWire News
Joint Statement Urging White House Coronavirus Task Force and Nation's Governors to Ensure Hydroxychloroquine Access During COVID-19 Crisis Lupus Foundation of America
Relationship between disease activity of rheumatoid arthritis and development of locomotive syndrome: A five-year longitudinal cohort study DocWire News
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata | Small Molecules | News Channels PipelineReview.com
Pfizer Announces Positive Top-Line Results from Third Phase 3 Trial of Abrocitinib for Moderate to Severe Atopic Dermatitis, Which Showed Improvements in Skin Clearance, Disease Extent and Severity, and Itch | Small Molecules | News Channels PipelineReview.com
All-cause and cause-specific mortality in persons with fibromyalgia and widespread pain: An observational study in 35,248 persons with rheumatoid arthritis, non-inflammatory rheumatic disorders and clinical fibromyalgia MD Linx
Visiongain Report: Global Rheumatoid Arthritis Drugs Market Estimated to Grow at a CAGR of 0.6% in the Second Half of the Forecast Period Yahoo Finance
Pfizer Announces Positive Top-Line Results from Third Phase 3 Trial of Abrocitinib for Moderate to Severe Atopic Dermatitis, Which Showed Improvements in Skin Clearance, Disease Extent and Severity, and Itch Business Wire